Back
Editas Medicine Vs. DocuSign Industry Stock Comparison
Sell
1
EDIT
Editas Medicine
Last Price:
$1.27
Seasonality Move:
-10.13%
Buy
67
DOCU
DocuSign
Last Price:
$87.06
Seasonality Move:
13.69%
Sell
1
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.37. The Score for EDIT is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 44.11 | Sell |
Chaikin Money Flow: | -164815 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.26 - 2.08) | Sell |
Bollinger Bands (100): | (1.21 - 2.59) | Sell |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.79 | Buy |
Relative Strength Index (14 RSI): | 52.04 | Buy |
Chaikin Money Flow: | -1420982 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.25 - 86.93) | Buy |
Bollinger Bands (100): | (77.49 - 94.21) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.41 | Sell |
20-day SMA: | 1.75 | Sell |
50-day SMA: | 1.49 | Sell |
200-day SMA: | 3.15 | Sell |
8-day EMA: | 0.3 | Buy |
20-day EMA: | 0.13 | Buy |
50-day EMA: | 0.05 | Buy |
200-day EMA: | 0.01 | Buy |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.41 | Buy |
20-day SMA: | 82.51 | Buy |
50-day SMA: | 88 | Sell |
200-day SMA: | 71.37 | Buy |
8-day EMA: | 18.91 | Buy |
20-day EMA: | 8.11 | Buy |
50-day EMA: | 3.34 | Buy |
200-day EMA: | 0.85 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
DocuSign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.66 per share, and a decrease next year of $0.03 per share.
Editas Medicine Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DocuSign Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |